EUVIMEDEUVIMED entdecken
Crossref

Integrated Forward and Reverse Degradomics of Aortic Aneurysms Uncovers Their Proteolytic Landscapes and the Roles of MMP9 and Mast Cell Chymase

Sumit Bhutada iD, Daniel R Martin iD, Frank Cikach iD, Emidio Germano da Silva iD, Belinda B Willard iD, Bhama Ramkhelawon iD, Mina K Chung iD, Shataakshi Dahal iD, Anand Ramamurthi iD, John Barnard iD, Eugene H Blackstone iD, Eric E Roselli iD und 1 weitere

Arteriosclerosis, Thrombosis, and Vascular Biology · 2026-05 · 46 (5)

DOI: 10.1161/atvbaha.125.323810 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026-05. Verfasst von Sumit Bhutada und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering (S.B., D.R.M., S.S.A.), Cleveland Clinic Research, Cleveland, OH. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 9, Chymases, Proteomics, Aortic Aneurysm, Abdominal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Dysregulated proteolysis is implicated in thoracic (thoracic aortic aneurysm [TAA]) and abdominal aortic aneurysm (AAA) pathogenesis, but proteolytic landscapes (degradomes) of aneurysmal and normal aorta and contributions of individual proteases remain undefined. Here, a proteome-wide approach was used to define and compare TAA and AAA degradomes and uncover the specific role in aortic remodeling of 2 proteases consistently identified in the aneurysms, CMA1 (mast cell chymase) and MMP9 (matrix metalloprotease 9). METHODS: The mass spectrometry-based N-terminomics strategy, terminal amine isotopic labeling of substrates, was applied to Marfan syndrome TAAs (n=5), AAAs (n=16), and nondiseased thoracic aorta (n=4), and abdominal aorta (n=4) in a forward degradomics application, that is, to define substrate and protease degradomes. 8-plex iTRAQ terminal amine isotopic labeling of substrates was used for quantitative comparison of the tissue cohorts. Cleavage sites of CMA1 and MMP9 were sought by reverse degradomics, that is, digestion of aortic proteins with these proteases, followed by terminal amine isotopic labeling of substrates. CMA1 and MMP9 proteolysis of biglycan was further resolved using amino-terminal oriented mass spectrometry of substrates. RESULTS: We experimentally annotated 20 885 proteolytically derived peptides and identified 129 proteases in the aortic tissues. Quantitative substrate degradome comparisons identified specific differentially modulated pathways and networks in TAAs and AAAs. Reverse degradomics elucidated >300 CMA1 and MMP9 substrate cleavage sites, of which many, including orthogonally validated biglycan cleavages, occurred in the disease degradomes. CONCLUSIONS: Unbiased forward degradomics of the aortic wall from TAA, AAA, and nondiseased tissue provides a systems biology view of aortic wall breakdown and a new resource for its hitherto occult proteolytic landscape, demonstrating widespread extracellular matrix remodeling with disproportionate impact on proteoglycans. The findings provided insights into aortic aneurysm pathways and disease biomarkers and suggest involvement of numerous proteases. Mapping of specific proteolytic contributions of CMA1 and MMP9 illustrates a strategy for defining the activities of all proteases involved in aortic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Matrix Metalloproteinase 9ChymasesProteomicsAortic Aneurysm, AbdominalMast CellsAortic Aneurysm, ThoracicAorta, ThoracicAorta, AbdominalHumansProteolysisVascular RemodelingMaleMass SpectrometryBiglycan

Stichwörter der Autor:innen

chymasesextracellular matrixinflammationmast cellsproteoglycansproteolysisproteome

Substanzen

Matrix Metalloproteinase 9ChymasesMMP9 protein, humanBGN protein, humanBiglycan

Autor:innen und Institutionen

  • Department of Biomedical Engineering (S.B., D.R.M., S.S.A.), Cleveland Clinic Research, Cleveland, OH.
  • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Heart and Vascular Institute, OH (F.C., E.G.S., E.H.B., E.E.R.).
  • Proteomics and Metabolomics Core, Cleveland Clinic Research, OH (B.B.W.).
  • Division of Vascular and Endovascular Surgery, Department of Surgery, New York University Langone Medical Center (B.R.).
  • Department of Cardiovascular and Metabolic Sciences (M.K.C.), Cleveland Clinic Research, Cleveland, OH.
  • Department of Cardiovascular Medicine, Cleveland Clinic Heart, Vascular and Thoracic Institute, OH (M.K.C.).

ORCID-Profile: Sumit Bhutada, Daniel R Martin, Frank Cikach, Emidio Germano da Silva, Belinda B Willard, Bhama Ramkhelawon, Mina K Chung, Shataakshi Dahal, Anand Ramamurthi, John Barnard, Eugene H Blackstone, Eric E Roselli, Suneel S Apte

Zitieren

APA

Bhutada, S., Martin, D. R., Cikach, F., Germano da Silva, E., Willard, B. B., Ramkhelawon, B., Chung, M. K., Dahal, S., Ramamurthi, A., Barnard, J., Blackstone, E. H., Roselli, E. E., & Apte, S. S. (2026). Integrated Forward and Reverse Degradomics of Aortic Aneurysms Uncovers Their Proteolytic Landscapes and the Roles of MMP9 and Mast Cell Chymase. Arteriosclerosis, Thrombosis, and Vascular Biology, 46(5). https://doi.org/10.1161/atvbaha.125.323810

Vancouver

Bhutada S, Martin DR, Cikach F, Germano da Silva E, Willard BB, Ramkhelawon B, et al. Integrated Forward and Reverse Degradomics of Aortic Aneurysms Uncovers Their Proteolytic Landscapes and the Roles of MMP9 and Mast Cell Chymase. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026;46(5). doi:10.1161/atvbaha.125.323810

BibTeX
@article{Bhutada2026,
  author = {Bhutada, Sumit and Martin, Daniel R and Cikach, Frank and Germano da Silva, Emidio and Willard, Belinda B and Ramkhelawon, Bhama and Chung, Mina K and Dahal, Shataakshi and Ramamurthi, Anand and Barnard, John and Blackstone, Eugene H and Roselli, Eric E and Apte, Suneel S},
  title = {Integrated Forward and Reverse Degradomics of Aortic Aneurysms Uncovers Their Proteolytic Landscapes and the Roles of MMP9 and Mast Cell Chymase},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2026},
  volume = {46},
  number = {5},
  doi = {10.1161/atvbaha.125.323810}
}
Kostenlos starten →